Regeneron Pharmaceuticals to buy bankrupt 23andMe in $256M deal

foxbusiness.com/markets/regeneron-pharmaceuticals-purchase-23andme-256m-deal

Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets.
The pharmaceutical company said it won the court-supervised auction of the genetic testing company, with Regeneron agreeing to pay $256 million for the…

This story appeared on foxbusiness.com, 2025-05-19 15:45:12.
The Entire Business World on a Single Page. Free to Use →